13F-HR filed by venBio Partners LLC
venBio Partners LLC filed this 13F-HR for the quarter ended 2026-09-30, accepted by EDGAR 2026-11-16 21:15:25 UTC, with 9 holding rows worth $495,928,000.
- Accession
- 0000905148-26-004927
- Filer
- CIK 1776382
- Filed
- 2026-11-16
- Accepted by EDGAR
- Ingested
- Source
- EDGAR live feed
13F report for Q3 2026
A holdings report, 9 entries on the cover page, a total value of $495,928,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $495,928,000 with VALUE read as dollars as filed, 13F file number 028-19529. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| PARABILIS MEDICINES INC COM | 698955101 | Stock | 5,266,697 | $170,061,646 | dollars as filed | |
| PHARVARIS NV | N69605108 | COMMON STOCK | 4,458,977 | $141,438,750 | dollars as filed | |
| ATTOVIA THERAPEUTICS INC | 04987L102 | COM | 4,181,366 | $71,668,613 | dollars as filed | |
| ACHIEVE LIFE SCIENCES INC | 004468500 | COMMON STOCK | 5,914,720 | $47,850,085 | dollars as filed | |
| ALUMIS INC | 022307102 | COM | 4,191,408 | $30,974,505 | dollars as filed | |
| ALX ONCOLOGY HOLDINGS INC | 00166B105 | COMMON STOCK | 12,884,638 | $17,909,647 | dollars as filed | |
| Yarrow Bioscience, Inc. | 92941V407 | Common Stock, $0.0001 par value | 554,769 | $12,493,398 | dollars as filed | |
| LYELL IMMUNOPHARMA INC COM NEW | 55083R203 | Stock | 337,697 | $3,306,054 | dollars as filed | |
| LISATA THERAPEUTICS INC | 128058302 | COM | 156,460 | $225,302 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0000905148-26-004927 | this filing | 2026-11-16 |